Pilot Study of Abequolixron (RGX-104) and Durvalumab in Lung Cancer
Condition: Non-Small Cell Lung Cancer Interventions: Drug: Durvalumab; Drug: Carboplatin; Drug: Abequolixron; Drug: Abraxane; Drug: Pemetrexed Sponsors: UNC Lineberger Comprehensive Cancer Center; AstraZeneca; Rgenix, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abraxane | Alimta | AstraZeneca | Cancer | Cancer & Oncology | Lung Cancer | Research | Study